Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Advances in Experimental Medicine and Biology|April 25, 2019
Sarcoma Stem Cell HeterogeneityJiri Hatina, Michaela Kripnerova, Katerina Houfkova, et al.
Diagnostics (Basel, Switzerland)|July 27, 2022
Applications of Liquid Biopsies in Non-Small-Cell Lung CancerMartin Pesta, Dattatrya Shetti, Vlastimil Kulda, et al.
Biomarkers in Medicine|July 22, 2021
The potential of miR-499 plasmatic level as a biomarker of obstructive sleep apnea syndromeDavid Slouka, Jindra Windrichova, Hana Rezackova, et al.
Cancers|September 2, 2020
The Level of Preoperative Plasma KRAS Mutations and CEA Predict Survival of Patients Undergoing Surgery for Colorectal Cancer Liver MetastasesJiri Polivka, Jindra Windrichova, Martin Pesta, et al.
Cells|December 9, 2020
Prognostic Significance of Lymph Node Examination by the OSNA Method in Lung Cancer Patients-Comparison with the Standard Histopathological ProcedureJosef Vodicka, Martin Pesta, Vlastimil Kulda, et al.
Cancers|June 26, 2019
Plasma microRNA Levels Combined with CEA and CA19-9 in the Follow-Up of Colorectal Cancer PatientsMartin Pesta, Radek Kucera, Ondrej Topolcan, et al.
Oncology Letters|February 2, 2018
Predictive relevance of miR-34a, miR-224 and miR-342 in patients with advanced squamous cell carcinoma of the lung undergoing palliative chemotherapyVlastimil Kulda, Martin Svaton, Petr Mukensnabl, et al.
Pathology, Research and Practice|May 2, 2024
BRAF mutation, selected miRNAs and genes expression in primary papillary thyroid carcinomas and local lymph node metastasesDavid Kalfert, Marie Ludvikova, Martin Pesta, et al.
In Vivo (Athens, Greece)|June 27, 2024
Prognostic Value of Tumor Tissue Up-regulated microRNAs in Clear Cell Renal Cell Carcinoma (ccRCC)Martin Pesta, Ivan Travnicek, Vlastimil Kulda, et al.
Anticancer Research|January 25, 2023
Preoperative Plasma miRNA Levels Predict Prognosis in Early-stage Malignant MelanomaMahyar Sharif Bagheri, Jiri Polivka, Inka Treskova, et al.
Pageof 2